Dow Up, Psyence Biomedical Up

All three major indices rose today.

The NASDAQ rose 86.69 points.

The DOW rose 115.00 points.

The S&P rose 18.33 points.

Stocks continued their advance as improving sentiment around geopolitical stability and steady economic conditions supported equities. Gains remained concentrated in growth sectors, with the broader market maintaining upward momentum toward record levels.

All this as Psyence Biomedical shares rose from $2.99 to end the day at $5.87 per share.

The move was was a sharp momentum-driven surge. Intraday trading showed the stock running from roughly the $2.80 range to near $10 at peak levels, indicating extreme volatility and heavy speculative activity.

This type of price action is consistent with a micro-float squeeze, where limited available shares combined with high volume can drive rapid upward moves. Increased attention around psychedelic medicine development and clinical expansion likely contributed to the surge, but the magnitude of the move suggests trading dynamics played a dominant role.

In combination, today's rally in Psyence Biomedical reflects a high-volatility, momentum-driven breakout in a thinly traded biotech stock, amplified by speculative demand rather than a conventional, single headline catalyst.